|
2024
|
G/S
|
Pharmaceutical preparations and substances; medicines for
human purposes. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparat... |
|
|
G/S
|
Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for t... |
|
|
G/S
|
Clinical studies and trials of anticancer drugs; providing information on clinical studies and tr... |
|
|
G/S
|
Clinical studies and trials of anticancer drugs; providing
information on clinical studies and t... |
|
|
Invention
|
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines.
Provided ... |
|
|
Invention
|
Dosage regimen of an anti-cdh6 antibody-drug conjugate.
The present disclosure relates to the fi... |
|
|
Invention
|
Benzotriazole compound.
The present invention aims to provide a medicament capable of treating a... |
|
|
Invention
|
Peptide library and use thereof.
Disclosed are compositions and method related to variants of SP... |
|
|
Invention
|
Anti-cd37 antibody-drug conjugate.
It is an object to provide an antibody specifically binding t... |
|
|
Invention
|
3-phenylpropylamine derivative. The purpose of the present invention is to provide a novel compou... |
|
|
Invention
|
Composition for cytotoxic t cell depletion.
Provided is a composition for cytotoxic T cell deple... |
|
|
Invention
|
Method for producing n-pyridylsulfonamide compound, pyridine compound, and crystal of n-pyridylsu... |
|
|
Invention
|
Sirna for suppressing expression of phospholamban. The present invention provides, for example, a... |
|
|
Invention
|
Sirna capable of suppressing expression of α-synuclein. The purpose of the present invention is, ... |
|
|
Invention
|
Antibody-drug conjugate.
As an antitumor drug which is excellent in terms of antitumor effect an... |
|
|
Invention
|
Method for producing compound encoded by oligonucleotide, and application thereof. The purpose of... |
|
|
Invention
|
Griseofulvin compound.
An object of the present invention is to provide a compound having an ant... |
|
|
Invention
|
Stable target editing guide rna having phosphate moiety modification introduced thereinto. Provid... |
|
|
Invention
|
Method for producing immune cells. Disclosed are a means capable of stably producing TCR-T cells ... |
|
|
Invention
|
Method for producing mrna. The present invention provides, for example, a method for producing mR... |
|
|
Invention
|
Method for producing an anti-lag-3 antibody.
Provided are methods for producing a monoclonal ant... |
|
|
G/S
|
Chemicals for industrial purposes, adhesives for industrial purposes not for stationery or househ... |
|
|
Invention
|
Antibody-drug conjugate production method including purification step using activated carbon mate... |
|
|
G/S
|
Providing financial assistance to patients in the nature of payment assistance for medications an... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leu... |
|
|
Invention
|
Combination of (anti-her3 antibody)-drug conjugate and rasg12c inhibitor. The present invention p... |
|
|
Invention
|
Pharmaceutical composition containing mirogabalin. The present invention addresses the problem of... |
|
|
Invention
|
Klk5 inhibitory peptide.
SPINK2 mutant peptide conjugates are provided that inhibit KLK5. The KL... |
|
|
Invention
|
Anti-sirpa antibody.
An anti-SIRPα antibody that can be used as a tumor agent and an anti-tumor ... |
|
|
Invention
|
Anti-garp antibody.
The present invention relates to an antibody that binds to GARP and is usefu... |
|
|
Invention
|
Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof.
Desired is development... |
|
|
Invention
|
Combination of antibody-drug conjugate and other medicine. The present invention provides: a phar... |
|
|
Invention
|
Combination of anti-b7-h3 antibody-drug conjugate with atr inhibitor or atm inhibitor. In one emb... |
|
|
Invention
|
Antibody-pyrrolobenzodiazepine derivative conjugate.
The present invention provides a novel anti... |
|
|
Invention
|
Therapeutic method for low-drug-sensitivity cancers by administration of anti-muc1 antibody-drug ... |
|
|
Invention
|
Method for producing lentinan. The purpose of the present invention is to provide a method for pr... |
|
|
Invention
|
Combination of anti-cdh6 antibody-drug conjugate and hif-2a inhibitor. The present invention prov... |
|
|
Invention
|
Anti-cd25 antibody and anti-cd25 antibody-drug conjugate. The present invention addresses the pro... |
|
|
Invention
|
Combination of anti-cdh6 antibody-drug conjugate with vegf inhibitor. The present invention provi... |
|
|
Invention
|
Peptide for treating age-related macular degeneration.
It is intended to provide a novel peptide... |
|
|
Invention
|
Method for producing antibody-drug conjugate.
Crystals of the compound represented by formula (1... |
|
|
Invention
|
Anti-lrrc15 antibody. [Problem] To provide a novel LRRC-15 antibody, or antigen-binding fragment ... |
|
|
Invention
|
Substituted benzene compound. The present invention addresses the problem of providing a compound... |
|
|
Invention
|
Peptide for treating retinitis pigmentosa.
To provide a novel pharmaceutical use of a peptide. A... |
|
2023
|
G/S
|
Conducting of clinical studies and trials of pharmaceuticals for others; providing information on... |
|
|
G/S
|
Clinical studies and trials of pharmaceuticals; providing
information on clinical studies and tr... |
|
|
Invention
|
Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, d... |
|
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
Invention
|
Combination of multispecific molecule and immune checkpoint inhibitor. Provided is a novel combin... |
|
|
Invention
|
Tsp1 inhibitor. The present invention provides a cyclic peptide represented by formula (I) [Chemi... |
|
2022
|
Invention
|
Combination of antibody-drug conjugate and atr inhibitor.
A pharmaceutical product for administr... |
|
|
Invention
|
Protease-cleavable masked antibodies.
This invention provides a novel masked antibody. The maske... |
|
|
Invention
|
Combination of antibody-drug conjugate and parp1 selective inhibitor.
A pharmaceutical product f... |
|
|
Invention
|
Pharmaceutical composition having excellent dissolution properties.
The present invention provid... |
|
|
Invention
|
Methods of treating chemotherapy-resistant cancer with an antibody-drug conjugate.
The present d... |
|
|
Invention
|
Hpv infectious disease vaccine.
Provided are lipid particles encapsulating a nucleic acid capabl... |
|
|
Invention
|
Novel dealkoxyphenylation reaction.
To provide a method for obtaining a dealkoxyphenylation prod... |
|
|
Invention
|
Glycan, and method for producing medicine containing glycan.
The present invention addresses the... |
|
2021
|
Invention
|
A scoring method for an anti-her2 antibody-drug conjugate therapy.
A method for predicting how a... |
|
|
Invention
|
Novel endo-ß-n-acetylglucosaminidase.
The present invention provides endo-β-N-acetylglucosaminid... |
